| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Total Operating Expense | 1,690.67 | 1,666.49 | 1,565.28 | 1,365.93 |
| Other Net | 21.31 | 11.24 | 11.47 | 4.48 |
| Diluted Weighted Average Shares | 54.84 | 53.53 | 51.12 | 50.22 |
| Depreciation/ Amortization | 36.43 | 28.98 | 33.47 | 27.93 |
| Operating Income | 115.02 | 145.09 | 125.16 | 51.60 |
| Net Income | 94.88 | 118.02 | 96.16 | 38.68 |
| Income Availableto Com Excl Extra Ord | 94.88 | 118.02 | 96.16 | 38.68 |
| Other Operating Expenses Total | 156.71 | 118.07 | 141.58 | 70.86 |
| Net Income Before Taxes | 119.92 | 155.11 | 135.42 | 55.76 |
| Minority Interest | -0.77 | 0.01 | -0.46 | 0.00 |
| Net Income After Taxes | 95.65 | 118.02 | 96.62 | 38.68 |
| Income Availableto Com Incl Extra Ord | 94.88 | 118.02 | 96.16 | 38.68 |
| Costof Revenue Total | 1,168.31 | 1,226.30 | 1,117.61 | 994.15 |
| Gross Profit | 637.38 | 585.28 | 572.82 | 423.38 |
| Interest Inc( Exp) Net- Non- Op Total | -16.41 | -1.22 | -1.21 | -0.32 |
| Unusual Expense( Income) | -25.83 | - | - | - |
| Diluted Net Income | 94.88 | 118.02 | 96.16 | 38.68 |
| DPS- Common Stock Primary Issue | 0.20 | 0.20 | - | - |
| Provisionfor Income Taxes | 24.27 | 37.09 | 38.80 | 17.08 |
| period Type | - | - | - | - |
| Net Income Before Extra Items | 94.88 | 118.02 | 96.16 | 38.68 |
| Total Revenue | 1,805.69 | 1,811.58 | 1,690.43 | 1,417.53 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Revenue | 1,805.69 | 1,811.58 | 1,690.43 | 1,417.53 |
| Selling/ General/ Admin Expenses Total | 355.04 | 289.44 | 267.42 | 269.92 |
| Diluted Normalized EPS | 1.35 | 2.20 | 1.88 | 0.77 |
| Diluted EPS Excluding Extra Ord Items | 1.73 | 2.20 | 1.88 | 0.77 |
| Research Development | - | 3.69 | 5.20 | 3.07 |
Morepen Laboratories Dividend Morepen Laboratories Bonus Morepen Laboratories News Morepen Laboratories AGM Morepen Laboratories Rights Morepen Laboratories Splits Morepen Laboratories Board Meetings Morepen Laboratories Key Metrics Morepen Laboratories Shareholdings Morepen Laboratories Balance Sheet Morepen Laboratories Cashflow Morepen Laboratories Q1 Results Morepen Laboratories Q2 Results Morepen Laboratories Q3 Results Morepen Laboratories Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.